Go Deep
Kidswell Bio Corporation
Kidswell Bio Corporation Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 19,103 | -18.9 | 4.03 | 1.35 | 90.20 |
Kidswell Bio Corporation Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 1,269,509,000.0 | 1,571,106,000.0 | 1,742,600,000.0 | 1,555,585,000.0 |
| Net Profit | 197,902,000.0 | -271,193,000.0 | -203,384,000.0 | -96,543,000.0 |
| EPS | 4.0 | — | — | — |
Kidswell Bio Corporation Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 6,589,923,000.0 | 5,082,053,000.0 | 2,431,235,000.0 | 2,776,240,000.0 | — |
| Net Profit | -413,994,000.0 | -21,140,000.0 | -1,422,078,000.0 | -657,434,000.0 | — |
| EPS | -8.5 | -0.5 | -40.2 | -20.8 | — |
Kidswell Bio Corporation Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 6,088,396,000.0 | 7,008,496,000.0 | 5,085,550,000.0 | 3,894,765,000.0 | — |
| Total Liabilities | 4,434,479,000.0 | 5,597,519,000.0 | 4,254,076,000.0 | 2,661,260,000.0 | — |
| Total Equity | 1,653,917,000.0 | 1,410,977,000.0 | 831,474,000.0 | 1,233,505,000.0 | — |
Owes vs Owns
Kidswell Bio Corporation owed ¥0.70 for every ¥1 it owned in Jun 2026, up from ¥0.68 in Mar 2023.
| Period | Jun 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.70× | 0.73× | 0.80× | 0.84× | 0.68× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Kidswell Bio Corporation Assets & Liabilities Breakdown (JPY millions)
What it owns — Mar 2026
Cash & short-term investments 54.1%Receivables 12.0%Inventory 6.0%Long-term investments 3.5%Other assets 24.1%
How it's funded — Mar 2026
Short-term debt 6.0%Long-term debt 35.9%Other liabilities 31.0%Shareholders' equity 27.2%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 3,294.9 | 2,995.4 | 2,231.4 | 1,067.2 |
| Receivables | 731.1 | 1,267.2 | 881.4 | 1,036.2 |
| Inventory | 363.6 | 1,475.1 | 875.7 | 635.3 |
| Fixed assets (tangible) | 17.6 | 1.2 | 1.3 | 1.5 |
| Intangible assets | 0.6 | 0.8 | 1.5 | 2.3 |
| Long-term investments | 212.3 | 283.1 | 138.2 | 173.2 |
| Other assets | 1,468.2 | 985.7 | 956.0 | 979.1 |
| Liabilities & equity | ||||
| Short-term debt | 362.5 | 657.0 | 737.0 | 375.0 |
| Long-term debt | 2,187.5 | 1,180.9 | 1,838.0 | 1,575.0 |
| Payables | 0.0 | 227.0 | 85.1 | 155.6 |
| Other liabilities | 1,884.5 | 3,532.6 | 1,593.9 | 555.7 |
| Shareholders' equity | 1,653.9 | 1,411.0 | 831.5 | 1,233.5 |
| Net tangible assets | 1,653.3 | 1,410.2 | 829.9 | 1,231.2 |
Kidswell Bio Corporation Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | -1,096,139,000.0 | 936,707,000.0 | -453,634,000.0 | -1,421,259,000.0 | — |
| Investing Activities | -12,624,000.0 | 65,077,000.0 | 0.0 | -28,825,000.0 | — |
| Financing Activities | 1,397,941,000.0 | -240,061,000.0 | 1,617,883,000.0 | 1,356,312,000.0 | — |